TargetMol

rac-NBI-74330

Product Code:
 
TAR-T26035
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26035-1mg1mg£141.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26035-5mg5mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26035-10mg10mg£319.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26035-25mg25mg£494.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26035-50mg50mg£683.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26035-100mg100mg£930.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
rac-NBI-74330 is an effective and selective CXCR3 antagonist.
CAS:
473722-68-8
Formula:
C32H27F4N5O3
Molecular Weight:
605.58
Pathway:
Immunology/Inflammation; Autophagy; GPCR/G Protein
Purity:
0.9785
SMILES:
O=C1C=2C=CC=NC2N=C(N1C3=CC=C(OCC)C=C3)C(N(C(=O)CC4=CC=C(F)C(=C4)C(F)(F)F)CC=5C=NC=CC5)C
Target:
CXCR

References

1. Piotrowska A, et al. Pharmacological blockade of CXCR3 by (?)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies. Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3418-3437.